{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:13:57Z","timestamp":1773299637552,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-14484"],"award-info":[{"award-number":["MOP-14484"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ejphar.2006.03.019","type":"journal-article","created":{"date-parts":[[2006,3,21]],"date-time":"2006-03-21T07:14:10Z","timestamp":1142925250000},"page":"232-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Poloxamer 407 (P-407)-mediated reduction in the gene expression of ATP-binding-cassette transporter A1 may contribute to increased cholesterol in peripheral tissues of P-407-treated rats"],"prefix":"10.1016","volume":"536","author":[{"given":"Thomas P.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Jaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine L.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Krawiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Pilar","family":"Alom-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Sachs-Barrable","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishor M.","family":"Wasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.03.019_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2006.03.019_bib2","doi-asserted-by":"crossref","first-page":"C20","DOI":"10.1152\/ajpcell.1988.254.1.C20","article-title":"Ion transport mediated by copolymers composed of polyoxyethylene and polyoxypropylene","volume":"254","author":"Atkinson","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2006.03.019_bib3","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0022-2275(20)31498-X","article-title":"Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis","volume":"42","author":"Attie","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2006.03.019_bib4","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)31521-2","article-title":"Catalysis of ACAT may be completed within the plane of the membrane: a working hypothesis","volume":"42","author":"Chang","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2006.03.019_bib5","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1021\/jm0255116","article-title":"Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines","volume":"45","author":"Collins","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2006.03.019_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0022-2275(20)30180-2","article-title":"Bareing it all: the adoption of LXR and FXR and their roles in lipid homeostasis","volume":"43","author":"Edwards","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2006.03.019_bib7","first-page":"301","article-title":"General procedures for separating lipid components of tissue","volume":"3","author":"Entenman","year":"1957","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2006.03.019_bib8","doi-asserted-by":"crossref","first-page":"25448","DOI":"10.1074\/jbc.M301189200","article-title":"Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells","volume":"278","author":"Hoekstra","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2006.03.019_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00005344-200404000-00016","article-title":"The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date","volume":"43","author":"Johnston","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.03.019_bib10","first-page":"83","article-title":"Toxicological evaluation of poloxamers for intramuscular use","volume":"39","author":"Johnston","year":"1985","journal-title":"J. Parenter. Sci. Technol."},{"key":"10.1016\/j.ejphar.2006.03.019_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/00005344-199705000-00003","article-title":"Effect of poloxamer 407 on the activity of microsomal 3-hydroxy-3-methylglutaryl coa reductase in rats","volume":"29","author":"Johnston","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.03.019_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1023\/A:1015815624334","article-title":"Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice","volume":"9","author":"Johnston","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2006.03.019_bib13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00005344-199912000-00010","article-title":"Potential down-regulation of hmg-coa reductase after prolonged administration of P-407 in C57BL\/6 mice","volume":"34","author":"Johnston","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.03.019_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(01)00834-1","article-title":"Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis","volume":"229","author":"Johnston","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2006.03.019_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/0962935031000134860","article-title":"Poloxamer 407-induced atherosclerosis in mice appears to be due to lipid derangements and not due to its direct effects on endothelial cells and macrophages","volume":"12","author":"Johnston","year":"2003","journal-title":"Med. Inflamm."},{"key":"10.1016\/j.ejphar.2006.03.019_bib16","doi-asserted-by":"crossref","first-page":"11019","DOI":"10.1074\/jbc.M111041200","article-title":"Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors","volume":"277","author":"Joseph","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2006.03.019_bib17","series-title":"Colloidal Carriers for Controlled Drug Delivery and Targeting","first-page":"207","article-title":"Toxicity studies in hepatocyte cultures","author":"Muller","year":"1991"},{"key":"10.1016\/j.ejphar.2006.03.019_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1388-1981(00)00157-8","article-title":"Tangier disease and ABCA1","volume":"1529","author":"Oram","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2006.03.019_bib19","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0022-2275(20)37453-8","article-title":"Apolipoprotein-mediated removal of cellular cholesterol and phospholipids","volume":"37","author":"Oram","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2006.03.019_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0021-9150(97)00193-7","article-title":"Poloxamer 407-induced atherogenesis in the C57BL\/6 mouse","volume":"136","author":"Palmer","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2006.03.019_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jps.2600810707","article-title":"Biological activity of urease formulated in poloxamer 407 following intraperitoneal injection in the rat","volume":"81","author":"Pec","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2006.03.019_bib22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/nm1102-1243","article-title":"The liver X receptor gene team: potential new players in atherosclerosis","volume":"8","author":"Repa","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2006.03.019_bib23","series-title":"Polymers for Controlled Drug Delivery","first-page":"189","article-title":"Poloxamers in the pharmaceutical industry","author":"Schmolka","year":"1991"},{"key":"10.1016\/j.ejphar.2006.03.019_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI0215748","article-title":"Increased ABCA1 activity protects against atherosclerosis","volume":"110","author":"Singaraja","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2006.03.019_bib25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1124\/dmd.31.10.1235","article-title":"Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine","volume":"31","author":"Takara","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2006.03.019_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00133-5","article-title":"Cholesterol in the year 2000","volume":"1529","author":"Vance","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2006.03.019_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-5173(94)00179-9","article-title":"Sustained release interleukin-2 following intramuscular injection in rats","volume":"113","author":"Wang","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2006.03.019_bib28","first-page":"108","article-title":"Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats","volume":"6","author":"Wasan","year":"2003","journal-title":"J. Pharm. Pharmaceut. Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906002731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906002731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:07:12Z","timestamp":1757974032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299906002731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0014299906002731"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.03.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poloxamer 407 (P-407)-mediated reduction in the gene expression of ATP-binding-cassette transporter A1 may contribute to increased cholesterol in peripheral tissues of P-407-treated rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}